Matches in Wikidata for { <http://www.wikidata.org/entity/Q91962285> ?p ?o ?g. }
- Q91962285 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q91962285 description "im Dezember 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91962285 description "scientific article published on 09 December 2019" @default.
- Q91962285 description "wetenschappelijk artikel" @default.
- Q91962285 description "наукова стаття, опублікована 9 грудня 2019" @default.
- Q91962285 name "Proteomic and Phosphoproteomic Analysis Reveals that Neurokinin-1 Receptor (NK1R) Blockade with Aprepitant in Human Keratinocytes Activates a Distinct Subdomain of EGFR Signaling: Implications for the Anti-Pruritic Activity of NK1R Antagonists" @default.
- Q91962285 name "Proteomic and Phosphoproteomic Analysis Reveals that Neurokinin-1 Receptor (NK1R) Blockade with Aprepitant in Human Keratinocytes Activates a Distinct Subdomain of EGFR Signaling: Implications for the Anti-Pruritic Activity of NK1R Antagonists" @default.
- Q91962285 type Item @default.
- Q91962285 label "Proteomic and Phosphoproteomic Analysis Reveals that Neurokinin-1 Receptor (NK1R) Blockade with Aprepitant in Human Keratinocytes Activates a Distinct Subdomain of EGFR Signaling: Implications for the Anti-Pruritic Activity of NK1R Antagonists" @default.
- Q91962285 label "Proteomic and Phosphoproteomic Analysis Reveals that Neurokinin-1 Receptor (NK1R) Blockade with Aprepitant in Human Keratinocytes Activates a Distinct Subdomain of EGFR Signaling: Implications for the Anti-Pruritic Activity of NK1R Antagonists" @default.
- Q91962285 prefLabel "Proteomic and Phosphoproteomic Analysis Reveals that Neurokinin-1 Receptor (NK1R) Blockade with Aprepitant in Human Keratinocytes Activates a Distinct Subdomain of EGFR Signaling: Implications for the Anti-Pruritic Activity of NK1R Antagonists" @default.
- Q91962285 prefLabel "Proteomic and Phosphoproteomic Analysis Reveals that Neurokinin-1 Receptor (NK1R) Blockade with Aprepitant in Human Keratinocytes Activates a Distinct Subdomain of EGFR Signaling: Implications for the Anti-Pruritic Activity of NK1R Antagonists" @default.
- Q91962285 P1433 Q91962285-62683108-3B89-4F16-9943-39B9705ACF3B @default.
- Q91962285 P1476 Q91962285-DF27D945-A390-4172-996B-5137A8DFE179 @default.
- Q91962285 P2093 Q91962285-2A10FD68-1A30-41F0-9FE1-0AA31E3C6966 @default.
- Q91962285 P2093 Q91962285-2E9CE97F-447A-4D1B-AC0B-2334022DCF20 @default.
- Q91962285 P2093 Q91962285-498975F0-0D65-4B6F-BDEF-9097855AD1A2 @default.
- Q91962285 P2093 Q91962285-611D49B5-2C56-495B-AFBC-290AB3D0D952 @default.
- Q91962285 P2093 Q91962285-90210C96-24AB-4BA5-AFD3-BB025B87415C @default.
- Q91962285 P2093 Q91962285-E4A4BCD6-A50B-4AA5-B533-BC6B16DC5C1B @default.
- Q91962285 P2093 Q91962285-FF8B6A44-C2DB-455F-B68D-7B981567D170 @default.
- Q91962285 P275 Q91962285-cfdda227-6d88-4357-8b04-58dd90cc110f @default.
- Q91962285 P2860 Q91962285-0F221027-B985-4BF1-8B7E-D2A167562B45 @default.
- Q91962285 P2860 Q91962285-113DB7AC-93DB-46FF-9AD9-F7B6FA29CAAC @default.
- Q91962285 P2860 Q91962285-1DA5CCA1-9DC0-40B9-B300-C6AC58E6BBA4 @default.
- Q91962285 P2860 Q91962285-31D00B56-85E7-453E-B1C6-94C2D158E18D @default.
- Q91962285 P2860 Q91962285-381B87F4-C6B1-4128-AF4A-847C3052A1A1 @default.
- Q91962285 P2860 Q91962285-45A3A83B-B6C7-4D57-A47B-22E555038AA1 @default.
- Q91962285 P2860 Q91962285-49883BD0-082A-4B30-8EEB-A66B9C2267E3 @default.
- Q91962285 P2860 Q91962285-7215942B-B4A4-448B-906B-E7B4E7B85DA0 @default.
- Q91962285 P2860 Q91962285-72D4F89E-6BA4-4613-97ED-A6BEC952F95A @default.
- Q91962285 P2860 Q91962285-8BE4C5E7-7BD6-4310-B05E-B3FF18D193B7 @default.
- Q91962285 P2860 Q91962285-95889F4E-16A8-47CB-876B-5A1AB6842077 @default.
- Q91962285 P2860 Q91962285-96C43B7D-094F-417B-979E-6FE363437245 @default.
- Q91962285 P2860 Q91962285-989AA641-FE5C-4744-B6B7-76E0235C3C24 @default.
- Q91962285 P2860 Q91962285-A905A40D-AA0F-4444-A017-6EBCE90AA952 @default.
- Q91962285 P2860 Q91962285-B6DAB2AA-0A35-43B4-BAAA-09D00DB99486 @default.
- Q91962285 P2860 Q91962285-B921E209-1D44-455E-8701-8DEF480AF5F0 @default.
- Q91962285 P2860 Q91962285-BCFB1F6F-03B3-44F5-8C0F-F7004121D0CA @default.
- Q91962285 P2860 Q91962285-C6D7CB3B-E3BF-45EC-8ED6-D940CBCB99E8 @default.
- Q91962285 P2860 Q91962285-D4D2FC34-3FFC-4B51-893D-523A7FFE3BD8 @default.
- Q91962285 P2860 Q91962285-D586A401-6CFE-4833-BCFE-47A7F2FE8690 @default.
- Q91962285 P2860 Q91962285-D5884A3D-72C4-4ECB-A1B0-0223B75734CC @default.
- Q91962285 P2860 Q91962285-D5D01F2B-231C-47DD-BD87-CB25D1C8C479 @default.
- Q91962285 P2860 Q91962285-DBCF7CC0-81E0-4AE4-817D-726847D0E100 @default.
- Q91962285 P31 Q91962285-FA736C39-D62D-4699-8B69-0AC1B3F30CB1 @default.
- Q91962285 P356 Q91962285-A32FF5CA-DE6C-47C7-99A8-2B7319241BA2 @default.
- Q91962285 P433 Q91962285-2DCCF077-6F10-4156-8A83-6846E3D31A31 @default.
- Q91962285 P478 Q91962285-E46112A8-4166-4DDC-80C8-D4433795DD8D @default.
- Q91962285 P50 Q91962285-433D9B3A-31C0-4CB7-B674-B2B0C70D7AE8 @default.
- Q91962285 P50 Q91962285-47292EAD-8BE0-4B27-9BDB-B46CF9B81D6D @default.
- Q91962285 P50 Q91962285-9A10EA10-594D-4D16-A26D-17D8FD9EBE5C @default.
- Q91962285 P50 Q91962285-A5842DE5-AA08-4D90-8BA1-5B54F93921AA @default.
- Q91962285 P577 Q91962285-F7F1B188-36DB-44E3-A3EF-802ADC98A37A @default.
- Q91962285 P6216 Q91962285-7a91210c-57f5-45f6-8560-c3b1db515daf @default.
- Q91962285 P698 Q91962285-B858236C-D24D-4D06-A188-9823CEC9F3D9 @default.
- Q91962285 P921 Q91962285-0BF79E73-DC07-4F0A-A88F-195286457715 @default.
- Q91962285 P932 Q91962285-1D01E08B-78C4-4CD5-9E09-EFBBDEA10875 @default.
- Q91962285 P356 MEDICINES6040114 @default.
- Q91962285 P698 31835310 @default.
- Q91962285 P1433 Q27726946 @default.
- Q91962285 P1476 "Proteomic and Phosphoproteomic Analysis Reveals that Neurokinin-1 Receptor (NK1R) Blockade with Aprepitant in Human Keratinocytes Activates a Distinct Subdomain of EGFR Signaling: Implications for the Anti-Pruritic Activity of NK1R Antagonists" @default.
- Q91962285 P2093 "Callie M Roberts" @default.
- Q91962285 P2093 "Cory Nanni" @default.
- Q91962285 P2093 "Kyle A Williams" @default.
- Q91962285 P2093 "Madan M Kwatra" @default.
- Q91962285 P2093 "Madison Krischak" @default.
- Q91962285 P2093 "Raveena Khanna" @default.
- Q91962285 P2093 "Robert F Burns" @default.
- Q91962285 P275 Q20007257 @default.
- Q91962285 P2860 Q30415389 @default.
- Q91962285 P2860 Q35083960 @default.
- Q91962285 P2860 Q35887828 @default.
- Q91962285 P2860 Q37227039 @default.
- Q91962285 P2860 Q37644848 @default.
- Q91962285 P2860 Q38893978 @default.
- Q91962285 P2860 Q39705448 @default.
- Q91962285 P2860 Q39894233 @default.
- Q91962285 P2860 Q40922182 @default.
- Q91962285 P2860 Q42957421 @default.
- Q91962285 P2860 Q43136628 @default.
- Q91962285 P2860 Q43268400 @default.
- Q91962285 P2860 Q43521257 @default.
- Q91962285 P2860 Q47141491 @default.
- Q91962285 P2860 Q47728732 @default.
- Q91962285 P2860 Q47728758 @default.
- Q91962285 P2860 Q49907390 @default.
- Q91962285 P2860 Q50438042 @default.
- Q91962285 P2860 Q54482291 @default.
- Q91962285 P2860 Q70711804 @default.
- Q91962285 P2860 Q73877492 @default.
- Q91962285 P2860 Q91455237 @default.
- Q91962285 P2860 Q92989945 @default.
- Q91962285 P31 Q13442814 @default.
- Q91962285 P356 "10.3390/MEDICINES6040114" @default.
- Q91962285 P433 "4" @default.
- Q91962285 P478 "6" @default.
- Q91962285 P50 Q58145562 @default.
- Q91962285 P50 Q58388244 @default.
- Q91962285 P50 Q88130003 @default.